| HOME >> BIOLOGY >> TECHNOLOGY |
ATLANTA, Aug. 27 /PRNewswire/ -- MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, announced today that CMS has approved the company as a vendor for the Centers for Medicare & Medicaid Services (CMS).
MDdatacor will automate the collection and submission of clinical information for CMS, relieving the administrative burden of having to hand-write data collection worksheets or manually enter data into a registry system. MDdatacor's patented and interoperable CareInformatix(TM) technology collects clinical data from physician practices' existing electronic medical record, practice management, lab and registry systems, regardless of vendor, as well as from transcribed notes.
Specifically, MDdatacor will submit quality measures data on behalf of providers to CMS as part of the organization's Physician Quality Reporting Initiative (PQRI) for 2008. PQRI is a voluntary pay-for-reporting program designed to improve the quality of patient care provided to Medicare beneficiaries. The program provides payment of up to 1.5% of the total allowed charges for covered Medicare physician fee schedule services to eligible healthcare professionals who successfully report PQRI quality measures.
"MDdatacor has a proven track record of providing physicians with tools that improve patient care while helping them achieve financial rewards for delivering high-quality, evidence-based care," said Tim Roche, co-founder, president and chief executive officer of MDdatacor. "The selection of MDdatacor as an approved CMS vendor demonstrates a viable alternative to using just claims data or manually collecting clinical data for PQRI reporting, even within organizations using disparate IT systems."
About MDdatacor
Established in 2001 and headquartered in Atlanta, Georgia, MDdatacor
enhances healthcare quality through the development of innovative
technology solutions. MDdatacor solutions are used to support
'/>"/>
| SOURCE MDdatacor, Inc. Copyright©2008 PR Newswire. All rights reserved |